Dice Therapeutics (NASDAQ: DICE)
Some price data may be temporarily unavailable.
Dice Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Dice Therapeutics Company Info
DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA.
News & Analysis
Featured Article
Why Dice Therapeutics Stock Bolted Higher This Week
The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.
George Budwell | Jun 22, 2023
Featured Article
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
The company received a buyout offer from Eli Lilly.
Jim Halley | Jun 20, 2023
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.